41 filings
SC 13D/A
IMAB
I-Mab
21 Dec 20
I-Mab / HILLHOUSE CAPITAL ADVISORS ownership change
4:05pm
SC 13G
YSG
Yatsen Holding Ltd
16 Dec 20
Yatsen Holding / HILLHOUSE CAPITAL ADVISORS ownership change
12:20pm
SC 13D/A
China Biologic Products Holdings, Inc.
23 Nov 20
China Biologic Products / HILLHOUSE CAPITAL ADVISORS ownership change
9:00am
13F-HR
Hillhouse Capital Advisors, LTD.
16 Nov 20
Quarterly holdings report by institutional manager
4:05pm
SC 13D/A
Hillhouse Capital Advisors, LTD.
28 Oct 20
China Biologic Products / HILLHOUSE CAPITAL ADVISORS ownership change
4:00pm
SC 13D/A
un93d5vr
18 Sep 20
China Biologic Products / HILLHOUSE CAPITAL ADVISORS ownership change
8:16am
SC 13D
7cymx
14 Sep 20
I-Mab / HILLHOUSE CAPITAL ADVISORS ownership change
5:19pm
13F-HR
zc081l cvq
14 Aug 20
Quarterly holdings report by institutional manager
3:05pm
SC 13D/A
e47wle09osq
14 Jul 20
BeiGene / HILLHOUSE CAPITAL ADVISORS ownership change
9:01am
3
ukkfh7h81m50ew6t3
14 Jul 20
Initial statement of insider ownership
9:00am
SC 13D/A
spej gtl1r
24 Jun 20
Cellular Biomedicine / HILLHOUSE CAPITAL ADVISORS ownership change
4:38pm
13F-HR
hej 2bs6ko
15 May 20
Quarterly holdings report by institutional manager
4:05pm
SC 13D/A
msl5r7nrd1k6nzmxky
8 May 20
China Biologic Products / HILLHOUSE CAPITAL ADVISORS ownership change
4:30pm
SC 13D/A
rym5d8jt6t8246e
30 Mar 20
Cellular Biomedicine / HILLHOUSE CAPITAL ADVISORS ownership change
12:00am
SC 13D/A
jnmo5mhpjiah zm
21 Feb 20
Cellular Biomedicine Group, Inc.
4:10pm
SC 13G
8u9o7 l68u53bvs4iom
14 Feb 20
Gossamer Bio, Inc.
4:29pm
SC 13G/A
3wl0bgc hsor6ba
14 Feb 20
Apellis Pharmaceuticals, Inc.
4:28pm
SC 13G
1p2h0v0bcwqf8b2reve9
14 Feb 20
Bilibili Inc.
4:27pm
SC 13G
zokeagns
14 Feb 20
Beneficial ownership report
4:27pm
SC 13G/A
trx b5bcux
14 Feb 20
Kiniksa Pharmaceuticals, Ltd.
4:24pm